Cambridge Antibody Technology Group Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jongmans who started this subject	5/6/2004 6:59:34 AM
From: nigel bates	Read Replies (1) of 625

European regulators support Abbott's Humira claim Thursday May 6, 6:27 am ET NEW YORK, May 6 (Reuters) - Abbott Laboratories Inc. (NYSE:ABT - News) said on Thursday European regulators have given their support to allow Abbott to market its arthritis drug Humira for reducing the rate of progression of joint damage and improving the physical function of patients. The European Union approved Humira for rheumatoid arthritis in September 2003. The positive opinion from the European Medicines Evaluation Agency about the broader label will be reviewed by the European Commission...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next